Stelar Metals Limited (ASX:SLB) has disclosed a change in the relevant interests of Non-Executive Director Dr Qingtao Zeng, following the issue of 1,000,000 unlisted options across two tranches on 3 November and 6 November 2026, as approved by shareholders at an extraordinary general meeting held on 9 October 2026.

Key Points

  • Dr Qingtao Zeng received 500,000 unlisted options on 3 November 2026 at a Black-Scholes valuation of $0.1618 per option, with an exercise price of $0.20 and expiry date of 9 October 2029.
  • A further 500,000 unlisted options were issued on 6 November 2026 at a Black-Scholes valuation of $0.147 per option, with an exercise price of $0.35 and expiry date of 9 October 2029.
  • Both tranches were issued as part of Dr Zeng's remuneration package negotiated on his commencement as Non-Executive Director, as approved by shareholders at the EGM on 9 October 2026.
  • Dr Zeng's direct holding of 369,122 fully paid ordinary shares remained unchanged, while Sunshine Fund Pty Ltd continues to hold 3,000,000 fully paid ordinary shares escrowed to 12 November 2026.

Option Issue Details and Valuation

According to the filing, the two tranches of unlisted options were issued to Dr Qingtao Zeng on 3 November and 6 November 2026 respectively. The first tranche of 500,000 options was valued at $0.1618 per option using the Black-Scholes valuation method, carrying an exercise price of $0.20 and an expiry date of 9 October 2029. The second tranche of 500,000 options was valued at $0.147 per option under the same method, with an exercise price of $0.35 and the same expiry date of 9 October 2029. No securities were disposed of in connection with either transaction.

Shareholder Approval and Remuneration Context

The filing states that both tranches of options were issued as part of the remuneration package negotiated with Dr Zeng upon his commencement as a Non-Executive Director of Stelar Metals Limited. Shareholder approval for both issuances was obtained at an extraordinary general meeting held on 9 October 2026. The filing confirms that neither transaction occurred during a closed period requiring prior written clearance, and no such clearance was sought or provided in relation to these securities.

Director's Securities Holdings After Change

Following the two option issuances, Dr Zeng's direct holding remains 369,122 fully paid ordinary shares. Through the indirect interest held by Sunshine Fund Pty Ltd, Dr Zeng continues to hold 3,000,000 fully paid ordinary shares, which the filing notes are escrowed to 12 November 2026. Additionally, Dr Zeng now holds indirectly through Sunshine Fund Pty Ltd the two tranches of unlisted options totalling 1,000,000, as detailed in the disclosure. The date of the previous director's interest notice was 14 July 2026.